Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORTHO-2: Autologous MSCs for Avascular Necrosis of the Femoral Head
NCT02065167Phase 2Completed
- Sponsor
- Universidad Autónoma de Madrid
- Start
- Feb 2014
- Primary completion
- Jun 2016
- Countries
- 4
01
Overview
A Phase 2 trial of autologous mesenchymal stem cells in avascular necrosis of the femoral head (AVN), sponsored by Universidad Autónoma de Madrid. Started Feb 2014; status: completed.
02
Drugs
autologous mesenchymal stem cells
03
Conditions
avascular necrosis of the femoral head (AVN)
Beyond the preview
Go deeper on NCT02065167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02065167.